Provided by Tiger Trade Technology Pte. Ltd.

Adagene

2.93
-0.2700-8.44%
Post-market: 2.89-0.0400-1.37%17:10 EDT
Volume:278.28K
Turnover:832.16K
Market Cap:196.73M
PE:-7.77
High:3.12
Open:3.12
Low:2.92
Close:3.20
52wk High:4.85
52wk Low:1.30
Shares:67.14M
Float Shares:42.20M
Volume Ratio:0.78
T/O Rate:0.66%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.3773
EPS(LYR):-0.3750
ROE:-28.50%
ROA:-13.95%
PB:2.20
PE(LYR):-7.81

Loading ...

Analysts Have Conflicting Sentiments on These Healthcare Companies: Roche Holding AG (OtherRHHVF), Adagene (ADAG) and Inventiva (IVA)

TIPRANKS
·
Sep 29

Adagene Announces Finance Executive Resignation Effective September 30, 2026

TIPRANKS
·
Sep 26

Adagene to Begin Phase 1 Study of Adg138 for Advanced Solid Tumors in Q4 2026

Reuters
·
Sep 22

Adagene Wins NMPA IND Clearance for Novel HER2xCD3 T-Cell Engager ADG138

TIPRANKS
·
Sep 22

Adagene Announces NMPA Clearance of Investigational New Drug Application for ADG138, a Novel HER2xCD3 Double-Masked Bispecific T-Cell Engager

GlobeNewswire
·
Sep 22

Adagene CEO Makes Bold Insider Move With Fresh Stock Purchase

TIPRANKS
·
Sep 18

Adagene CEO Peter Luo Buys 20,290 ADS Worth $63,974.40

Reuters
·
Sep 17

Adagene Price Target Maintained with a $7.00/Share by HC Wainwright & Co.

Dow Jones
·
Sep 14

Analysts’ Top Healthcare Picks: Adagene (ADAG), AbbVie (ABBV)

TIPRANKS
·
Sep 11

Adagene’s Platform Partnerships and Muzastotug Catalysts Support Buy Rating, Price Target Unchanged at $8

TIPRANKS
·
Sep 10

Adagene, Third Arc Bio Expand SAFEbody Masked CD3 T-Cell Engager Collaboration with First Lead Pick

Reuters
·
Sep 10

Adagene Initiated at Buy by Chardan Capital

Dow Jones
·
Sep 10

Chardan Initiates Adagene at Buy With $9 Price Target

MT Newswires Live
·
Sep 10

Adagene initiated with a Buy at Chardan

TIPRANKS
·
Sep 10

Adagene Receives Milestone Payment From Exelixis

MT Newswires Live
·
Sep 09

Adagene Secures Milestone Payments in Exelixis SAFEbody ADC Collaboration

TIPRANKS
·
Sep 09

Adagene Receives USD 2 Million Exelixis Milestone Payment for SAFEbody ADC Program

Reuters
·
Sep 09

Adagene Hits Preclinical Milestone for Exelixis-Partnered XB404 SAFEbody ADC, Triggers $2 Million Payment

Reuters
·
Sep 09

Adagene Achieves Milestone in Collaboration with Exelixis for Advancement of SAFEbody® Antibody-Drug Conjugate Candidates

GlobeNewswire
·
Sep 09

Adagene Posts Investor Presentation on Masked Anti-CTLA-4 Program Adg126

Reuters
·
Sep 04